ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Yarbro Proposal, Clinical Research Should Be “Fun”, Done Without Grants/ Contracts, To Be Heard By ACCC

September 10, 1982

Blinatumomab Shows Response In Adults with Refractory ALL

May 25, 2012

Harvard’s DePinho Becomes Finalist at MD Anderson

May 20, 2011

In Brief: Nabel To Direct Vaccine Research Center; Former NIH Director Robert Marston Is Dead

March 19, 1999

Research Dollars Save Money, Lives, Scientists Tell Senate

May 3, 1991

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997